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Introduction. Free trisomy 21 is responsible for 95% of Down syndrome cases. Advanced
maternal age and susceptible recombination patterns are recognized risk factors associated to
Down syndrome. Maternal origin of trisomy occurs in approximately 90% of cases; paternal
and mitotic origin share the remaining 10%. However, the recombination events that serve as
a risk factors for trisomy 21 have not been carefully characterized.
Objective. To analyze and validate observations in a sample of Colombian trysonomy 21
cases.
Materials and methods. Twenty-two Colombian families were selected, each with one affected
Down syndrome (free trisomy 21) child. Microsatellite polymorphisms were used as DNA markers
to determine the parental/stage origin of non-disjunction and recombination events. Non-
parametric tests were used to compare our results with those reported. Multiple correspondence
analysis was used to outline different groups and their associations.
Results. Distribution of trisomy 21 was 90.9% maternal, 4.5% paternal and 4.5% from mitotic
origin, similar to distributions reported previously. However, we found differences in the
frequency of maternal meiotic stage errors between the present study (46.1% meiosis I and
53.9% meiosis II) compared to those reported previously (70% meiosis I and 30% meiosis II).
Multiple correspondence analyses showed association of either local recombination events or
absence of recombination with specific non-disjunction stages.
Conclusions. Recombination patterns found in this study support the hypothesis that susceptible
chiasmate configurations are associated to maternal meiosis I and meiosis II errors. Non-
disjunction frequencies between maternal meiotic stages need to be clarified in our population.
Key words: Down syndrome; nondisjunction, genetic; trisomy; meiosis; recombination, genetic;
microsatellite repeats.
Origen parental, estado de no disyunción y recombinación meiótica del cromosoma 21
extra en el síndrome de Down: estudio en una muestra de población colombiana
Introducción. La trisomía 21 libre es responsable del 95% de los casos de síndrome de Down.
La edad materna y la recombinación son los principales factores de riesgo asociados con la
concepción de estos individuos. El origen materno de la trisomía ocurre en el 90% de los
casos, mientras que los casos de origen paterno y mitótico comparten un 10%. Por otra parte,
la recombinación como factor de riesgo para la trisomía 21 no ha sido comprobada
completamente.
Objetivo. Analizar y validar estas observaciones en una muestra colombiana de casos con
trisomía 21 libre.
Materiales y métodos. Se estudiaron 22 afectados con síndrome de Down (trisomía libre) y
sus respectivos padres. Se usaron marcadores microsatélites de ADN para determinar el
origen en los progenitores, el estado de no disyunción y los eventos de recombinación. Por
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medio de pruebas no paramétricas se compararon los resultados con los reportados en la
literatura. Se realizó análisis de correspondencias múltiples para reconocer los diferentes
grupos y sus asociaciones.
Resultados. La distribución de la trisomía 21 fue 90,9% materna, 4,5% paterna y 4,5% mitótica,
similar a las reportadas previamente. Sin embargo, existen diferencias en la frecuencia de
errores del estado meiótico para origen materno (46,1% meiosis I y 53,9% meiosis II) comparada
con la de los reportados previamente (70% meiosis I y 30% meiosis II). El análisis de
correspondencias múltiples mostró asociación entre eventos de recombinación local y ausencia
de recombinación con estados de no disyunción específicos.
Conclusiones. Las configuraciones quiasmáticas susceptibles están asociadas de manera
específica a errores en la meiosis I y la meiosis II materna. Es necesario clasificar la frecuencia
de no disyunción en estados meióticos maternos en nuestra población.
Palabras clave: síndrome de Down, no disyunción genética, trisomía, meiosis, recombinación
genética, repeticiones de microsatélite.
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Trisomy 21 (Down syndrome) is the most commonly
occurring supernumerary chromosome anomaly
leading to mental retardation. The extra chromo-
some 21 arises as a consequence of non-dis-
junction during meiosis in gametes or during
postzygotic mitosis.
Down syndrome prevalence rates differ by
ethnicity and culture. Hispanics have higher rates
of Down syndrome than other genetic back-
grounds (1,2). For instance, an incidence of 1 in
700 has been reported for Hispanics living in the
USA, less than 1 in 600 in several non-related
Latin-American populations, 1 in 1,075 for USA
Caucasians, and  1 in 700 to 1 in 1,000 for other
Caucasian populations (3-6). These rates are also
affected by the number of pregnancies terminated
as a consequence of prenatal screening.
Recent evidence indicated a significantly greater
risk of Down syndrome in live and stillbirths among
Hispanic women than those of Caucasian women
(7). Additionally, a higher risk of Down syndrome
was found in foreign-born Hispanic women [1,7]
compared to Hispanic women and Caucasian non-
Hispanic women born in the United States [1,2].
Carothers et al. suggested an increased rate of
Down syndrome among US residents of Mexican
or Central American origin (8), but these rates were
not corroborated in a study that included data from
nine South American countries in a non-population
based study (9).
Colombia, which is composed mainly of
Caucasian-Mestizo and African descendent
populations (10), has a Down syndrome incidence
around 1 in 600 (11,12) and recently was estimated
as 1 in 578 (Ignacio Manuel Zarante, ECLAM,
personal communication).
Several studies have used DNA polymorphisms
to identify the origin of the extra chromosome 21
(13-15). In the largest meta-analysis study of 807
Down syndrome patients, the parental origin was
maternal in 90.7% of cases, paternal in 5.5% and
mitotic in the remaining 3.8% (16). Additionally,
when pericentromeric microsatellite markers were
used to detect the meiotic stage of non-
disjunction,  76% of maternal cases were found
to occur at meiosis I (MI) and 24% at meiosis II
(MII); in the cases of paternal origin, a 1:1 ratio
between stages was found, with a slight excess
of MII errors (13).
Recombination is a second important source of
non-disjunction (after maternal age) and is the only
subcellular event related to this process in humans
(17,18). The associations between (a) specific
meiotic errors and (b) absence of or localized
recombination suggested that all non-disjunction
events are initiated during MI and then resolved
at either MI or MII (19).
In the current study, the parental origin, the
meiotic/mitotic stage of origin, and the effect of
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recombination events on the production of trisomy
21 are determined in a sample of Colombian
families with Down syndrome children.
Materials and methods
Sampling
The population sample consisted of 22 young
Colombian probands clinically diagnosed and
cytogenetically verified as Down syndrome
patients (free trisomy 21), as well as their
progenitors. All families were living in Bogotá, but
had immigrated from different parts of Colombia
and were analyzed at Instituto de Genética,
Universidad Nacional de Colombia. The average
age of Down syndrome children was 3.2 years
(range 0–18). Average maternal age at the time
admission to the study was 31.5±10.2 years, and
average paternal age was 35.7±14.0 years.
Parental age at the time of the patient’s medical
examination was considered in order to assess
the temporal environmental conditions for possible
risk factors during Down syndrome conceptions.
Informed consent was obtained from parents in
all cases. All the procedures were in accordance
with the ethical standards of the Universidad
Nacional de Colombia Ethical Committee on
Human Experimentation and with the Helsinki
Declaration (20).
DNA studies
High molecular-weight genomic DNA was
extracted from peripheral blood cells from
probands and their parents. Six microsatellite
polymorphisms of chromosome 21 were isolated
using PCR amplification and separated by PAGE
(polyacrylamide gel electrophoresis). The set of
microsatellites, arrayed between the centromere
and telomere of the long arm of chromosome 21,
included: D21S1432, D21S11, D21S1437, APP
Intron 7, D21S1411, and PFKL (Figure 1).
PCR amplification was carried out in 25µl final
volume as described elsewere (21); annealing
temperatures for each microsatellite marker were
according with manufacturer recommendations.
PAGE was carried out in 6-8% acrylamide–bis-
acrylamide denaturing gels depending on fragment
sizes for each STR (short tandem repeat). Gels
were silver nitrate stained (Figure 2).
Definition of the parental origin, the meiotic/mitotic
stage of origin and recombination events
Parental origin was determined by the results from
at least two STR markers using digital dosage
analysis with Scion Image (version Beta 4.0.2).
The determination was possible when two variant
alleles were present in the proband, or by
comparing the polymorphic alleles when three
different alleles were present in the proband.
Subsequently, the meiotic stage of origin of
trisomy was determined by the state of reduction
in chromosome 21 pericentromeric markers of the
parent who had contributed the extra chromosome.
If parental heterozygosity was retained in the
trisomic offspring, the error occurred during MI,
and if parental heterozygosity was reduced to
homozygosity, the error occurred during MII or
Figure 1. Ideogram of chromosome 21 with intervals
according to STR markers used. PI (proximal interval), MI
(medial interval), DI (distal interval), Tel (telomere), Cen
(centromere).
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mitosis. Mitotic errors were distinguished from MII
errors by evaluating non-pericentromeric markers.
If a trisomic individual was reduced to
homozygosity at the informative loci, a post-
zygotic origin was inferred. If the trisomic individual
was not reduced to homozygosity at one or more
loci, a MII origin was indicated.
For recombination analysis, the 21q chromosome
was treated in three recombinational intervals as
follows: D21S1432-D21S11 was the proximal
interval, D21S11-D21S1411 was the medial
interval, and D21S1411-PFKL was the distal
interval (Figure 1).
Statistical analysis
A chi-squared test for k proportions was used to
compare parental origin and meiotic stage with
those reported elsewhere (22). Student‘s t-test was
used to compare mean ages between maternal
subgroups.
We used multiple correspondence analyses
(MCA) to qualitatively detect factors influencing
maternal non-disjunction. The MCA represented
categories as points in a multidimensional space.
The distance between points, defined according
to a chi-square metric, expressed the dissimilarities
between categories. MCA provided a low-
Figure 2. Example of analysis polymorphisms by PAGE (polyacrylamide gel electrophresis). All STR markers shown cases
of maternal non-disjunction origin, with two (one of them in double dosage -arrows) or three alleles. Fa (father), Mo (mother),
HN (normal sibling), Pr (proband).
dimensional picture that approximated the
structure of the cluster of points in the space
identified in the first factorial axes, which were the
axes of maximum dispersion of the cluster. For
graphical illustration, only the two axes providing
the largest amount of information were used. MCA
was performed only for 13 cases of maternal origin
with known meiotic stage. Meiotic stage,
recombination position, maternal and paternal age
at child birth, proband sex, and parity at Down
syndrome child birth were the categorical variables.
A contingency table was constructed, including
the results for each variable and for each individual.
The MCA was made with the Statistical Package
for Augmented Designs (SPAD) (version 5.5).
Results
Parental origin and meiotic stage were determined
for 22 probands with Down syndrome, consistint
of 15 males and 7 females. Mean maternal age at
proband birth was 28.1 years (range 14-41 years)
and mean paternal age was 34.1 years (range 18-
52 years).
Parental origin was determined in all cases.
Maternal origin was determined in 20 cases
(90.9%), paternal in one case (4.6%) and mitotic
in one case (4.6%) (Table 1). Meiotic or mitotic
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Table 1. Parental origin of chromosome 21 and stage of nondisjunction error based on DNA markers.
Parental origin and meiotic stage of nondisjunction Cases  (%)
Maternal origin
     Meiosis I 6 (27.3)
     Meiosis II 7 (31.8)
     Meiotic origin not determined 7 (31.8)
     Subtotal 20 (90.9)
Paternal origin-meiotic origin not determined 1 (4.5)
Mitotic origin 1 (4.5)
Total 22 (100)
origin of the extra chromosome 21 was identified
in 14 of 22 cases. Six cases were consistent with
MI error, seven with MII error, and one with mitotic
error (Table 1). All meiotic cases (MI: 46,15%;
MII: 53,87%) were maternal in origin. The mean
and the standard deviation of maternal age (at
proband birth)  in families with trisomy of maternal
origin, but unknown meiotic origin, was 27.8±8.0
years; in families with maternal MI errors the age
was 22.8±7.7 years; and in families with maternal
MII errors the age was 27.7±8.0 years. Not
statistically significant differences were seen
among the maternal ages.
The number and location of crossovers were
obtained for disjoined chromosomes of maternal
MI cases (n=6) and maternal MII cases (n=7)
(Table 2). Distal positioning exchange (one case)
and possible achiasmate chromosomes (five
cases) were noted for maternal MI cases. In
maternal MII cases, recombination events
occurred in the proximal (four cases) and medial
intervals (three cases). Additionally, single
recombination events were found in three
undetermined maternal cases.
Table 2. Recombinations registered in chromosome 21 intervals. Shown are the recombination events detected. Only  one
recombination event per proband analyzed was observed. In 6 cases the microsatellites used were un-informative about
recombination. R (no recombination), SND (stage not determined).
                                                                                              Recombination events
Recombination intervals Meiosis I Meiosis II SND
Proximal (D21S1432-D21S11) 4
Medial (D21S11-D21S1411) 3 2
Distal (D21S1411-PFKL) 1
NR 5 1
Total 6 7 3
Graphical representation of MCA (Figure 3) shows
that the better scattered variables along both
dimensions (factor axes) were recombination,
meiotic stage of non-disjunction  and maternal age.
This analysis separated two groups of factors: (1)
MII, medial or proximal recombination, and
mothers at least 29 years old (at proband birth)
were associated, and (2) MI, distal or possibly no
recombination and mothers with less than 29
years. Parity (Down syndrome position), proband
gender and paternal age did not seem associated
with any of the groups.
Discussion
The results of parental origin of trisomy 21 were
not different from those already reported (16,18,23).
Warren et al. first  suggested that reduced chi-
asma formation along chromosome 21 predis-
poses it to non-disjunction  errors (24). The above
data suggest two clusters (Figure 3, dashed ovals),
the first is the MI-No recombination-distal recom-
bination cluster and the second is the MII-Proxi-
mal recombination-medial recombination cluster.
Presence of these clusters support the hypoth-
146
Biomédica 2007;27:141-8Ramírez NJ, Belalcazar HM, Yunis JJ et al
esis that almost all non-disjunction  cases are the
result of errors initiated at MI (19,25).
In maternal cases, the stage of non-disjunction
was determined in 13 of 20 cases. Seven were at
MI, and 8 at MII. These data differ significantly
(p<0.01) from those previously described (16).
These differences may have diverse explanations:
first, a reduced sample size have led to random
statistical variation rather than to a real effect;
second, an increment in true MII errors (those who
are not associated with proximal recombination)
raises the number of MII cases. Third, an increase
in non-disjunction events associated with proximal
recombination events recorded as “MII”, as seen
the cause in the present results. Despite of the
small sample size, the proportions of parental
origin data and recombination patterns were similar
to those found in other studies and they seem not
be affected by random. On the other hand, studies
with “reduced” sample size did not found
differences analyzing meiotic stage in trisomies
compared with those reported for large samples
(14,26,27)
Since cases of proximal recombination and medial
recombination are equally associated to MII errors
Figure 3. Factorial plane of factor 1 vs factor 2 from MCA (multiple correspondence analyses). The variables (dark
squares) are possible risk factors for chromosome non-disjunction. Families are represented by open circles. Dashed lines
enclose the two clusters found. Rec (recombination), Fa (fathers), Mo (mothers), Parity 1 (at least two sons at proband
birth), Parity 2 (three or more sons at proband birth).
(Figure 3), the other alternatives cannot be
eliminated. One explanation is that non-disjunction
has multifactorial influences, where age plays a
role in some cases but not in others, and where
other influencing factors act globally in cells or
locally in chromosomes (17). Recombination is
also a multifactorial trait affecting chromosome
segregation, and it has been reported that
alteration of crossover patterns in gametes is
associated with non-disjunction (17,28). To
determine whether recombination-associated
factors or independent factors are responsible for
these results, further investigation is required.
In the current study, mothers less than 29 years
old (at the child’s birth) clustered with MI errors,
and mothers older than 29 years clustered with
MII errors. Although no significant differences in
maternal mean age were detected between MI and
MII cases, this tendency is a constant in others
studies (16,18,23).
The molecular correlates of non-disjunction in
oocytes involve several mechanisms: chromosome
condensation (29,30), pairing of homologous
chromosomes (31,32), synaptonemal complex
formation (33,34), recombination events (35,36),
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spindle formation (37,38) and meiotic checkpoints
(39,40). Proteins actively functioning in these
processes are essential for proper development,
but their specific roles in oocyte maturation are
difficult to unravel. The “two hit” model proposed
in 1996 (25) and extended recently (41) offer an
alternative explanation to non-disjunction cases
involving recombination. Susceptible recombinants
generate a first hit, and then a second hit, related
to mother age, triggers non-disjunction  events.
Cases in which recombination did not generate
susceptible configurations possibly involve subtle
modifications (for instance, SNP coding variations
for effector proteins) in any of the mechanisms
listed above.
In summary, the Colombian sample indicates an
interesting population which free trisomy 21
allocates non-disjunction events in different
proportion to the meiotic stages. To substantiate
these observations, additional studies in other
populations with a similar background must be
undertaken. Additional epidemiological and
molecular studies will be important in order to
interpret these results within the framework of a
possible high incidence of Down syndrome in
Colombia.
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